Objective: To investigate the relationship between serum specific serine protease inhibitor(Vaspin), adipose triglyceride lipase(ATGL) and risk factors and severity of coronary heart disease(CHD) in elderly patients. Methods: One hundred and twenty-four CHD patients(CHD group) and 80 healthy subjects(NC group) were selected. The clinical data of the two groups were collected. CHD-related hematological parameters were measured on the second day after admission. Coronary angiography was performed to assess the extent of coronary artery stenosis with Gensini score. Other indicators were recorded in the NC group except Gensini score and the results were then analyzed. Results: (1) The systolic blood pressure, diastolic blood pressure, body weight, BMI, smoking index, alcohol index, salt intake in CHD group were higher than those in NC group(P<0.05). (2) Vaspin, ATGL, INR, HDL-C of CHD group were lower than those of the NC group(P<0.05).The levels of FIB, TC, TG, LDL-C, Lp(a), blood glucose in CHD group were higher than those of NC group(P<0.05). No obvious coronary stenosis was found in NC group, and the improved Gensini score was 22.86±8.09 in CHD group. (3) Levels of Vaspin and ATGL were negatively correlated with systolic blood pressure, diastolic blood pressure, body weight, BMI, smoking index, drinking index and salt intake(P<0.05). (4) Vaspin and ATGL were negatively correlated with FIB, TC, TG, LDL-C, Lp(a), blood glucose, Gensini score(P<0.05),but positively correlated with INR and HDL-C(P<0.05). Conclusion: Vaspin and ATGL are closely related to the risk factors and the severity of coronary heart disease. Coronary heart disease risk factors may cause or aggravate the system disorder of body's sugar, lipid metabolism and coagulation, which may affect Vaspin and ATGL levels. Vaspin and ATGL may be a protective factor participating in the maintenance of metabolic balance. |
[1] 张琳,王馨,张晓东,等.冠心病患者视黄醇结合蛋白4及丝氨酸蛋白酶抑制剂水平分析[J].中国药物与临床,2016,16(7):947-950.
[2] 陈磊磊,王泽穆,陈波,等.脂肪因子Vaspin表达水平与冠心病的相关性[J].江苏医药,2014,40(24):2981-2984.
[3] KARBEK B,BOZKURT N C,TOPALOGLU O,et al.Relationship of vaspin and apelin levels with insulin resistance and atherosclerosis in metabolic syndrome[J].Minerva Endocrinologica,2014,39(2):99-105.
[4] HUO Y,LIU S X,SONG G Y,et al.Plasma levels and placental expression of vaspin in pregnant women with diabetes mellitus[J].Braz J Med Biol Res,2015,48(3):273-279.
[5] 陈磊磊,王泽穆,陈波,等.脂肪因子Vaspin表达水平与冠心病的相关性[J].江苏医药,2014,40(24):2981-2984.
[6] 中华医学会心血管病学分会,中华心血管病杂志编辑委员会.慢性稳定性心绞痛诊断与治疗指南[J].中华心血管病杂志,2007,35(3):195-206.
[7] 张爽,袁杰.糖代谢异常与冠心病关系的研究现状[J].东南大学学报:医学版,2016,35(4):602-606.
[8] 衡卫军,卢姗,马向华,等.吸烟指数与新发2型糖尿病动脉粥样硬化相关因素的研究[J].南京医科大学学报:自然科学版,2013,33(11):1597-1599.
[9] 王强,宫剑滨,张启高,等.血浆脂肪细胞因子与冠心病及糖尿病的相关性研究[J].中华实用诊断与治疗杂志,2014,27(6):551-553.
[10] HEIKER J T,KLOTING N,KOVACS P,et al.Vaspin inhibits kallikrein 7 by serpin mechanism[J].Cell Mol Life Sci,2013,70(14):2569-2583.
[11] 肖园园,曾朝阳,田晓年,等.新诊断2型糖尿病患者内脂素、vaspin与颈动脉粥样硬化的相关性[J].临床内科杂志,2013,30(1):697-699.
[12] 李海玲,彭文辉,崔世涛,等.血浆vaspin浓度与不稳定型心绞痛的相关性研究[J].临床心血管病杂志,2011,27(7):514-518. |